FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileConexeu Sciences Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CNXU
Conexeu Sciences Inc. Stock AnalysisComprehensive stock analysis for Conexeu Sciences Inc. (CNXU) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCNXU
CNXU
Conexeu Sciences Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CNXU
  1. Home
  2. Stocks
  3. Conexeu Sciences Inc.

Conexeu Sciences Inc.

🇺🇸CNXU•NASDAQ

Conexeu Sciences Inc.

🇺🇸CNXU•NASDAQ
Market cap
$47.79M

Your view on CNXU

Mkt Cap
$47.79M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Conexeu Sciences Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Miles Harrison
Headquarters
50 W Liberty St, Suite 880, Reno, NV, US
Industry
Biotechnology
Sector
Healthcare
CEO
Miles Harrison
Headquarters
50 W Liberty St, Suite 880, Reno, NV, US
Description

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R.

Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Conexeu Sciences Inc.. Starting points for Conexeu Sciences Inc.: EPS -$0.20, beta 0.51 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Conexeu Sciences Inc.. Trailing twelve-month EPS for Conexeu Sciences Inc. stands at -$0.20. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Conexeu Sciences Inc.. Conexeu Sciences Inc. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CNXU12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
INDPIndaptus Therapeutics, Inc.HealthcareNASDAQ$319.3M
INFIQInfinity Pharmaceuticals, Inc.HealthcareOTC$9,076
INKTMiNK Therapeutics, Inc.HealthcareNASDAQ$41.2M
INMBINmune Bio, Inc.HealthcareNASDAQ$25.6M
INNMFAmplia Therapeutics LimitedHealthcareOTC$30.8M
INOInovio Pharmaceuticals, Inc.HealthcareNASDAQ$121.6M
GLOW.CNGlow Lifetech Corp.HealthcareCNQ$10.9M
GLPGFGalapagos N.V.HealthcareOTC$2.2B
GLSHQGelesis Holdings, Inc.HealthcareOTC$7,334
GLSIGreenwich LifeSciences, Inc.HealthcareNASDAQ$282.6M
GLTOGalecto, Inc.HealthcareNASDAQ$34.5M
GLUEMonte Rosa Therapeutics, Inc.HealthcareNASDAQ$738.3M
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Conexeu Sciences Inc. executives and directors. Shares of Conexeu Sciences Inc. have traded between $7.10 and $18.79 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Conexeu Sciences Inc.. Coverage tracks Conexeu Sciences Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Conexeu Sciences Inc.

CNXU AnalysisWeak
Past
1
Growth
0
Health
0
Profit
0
Value
0